Patients testimonies

Patients at the Heart of INTERCEPTOR

 

The INTERCEPTOR COST Action is fundamentally dedicated to engaging with and learning from those most directly affected, the patients. This space is dedicated to sharing patient testimonies, bringing their lived experiences with oral potentially malignant disorders (OPMD) into focus. Their voices are vital, not only to raise awareness but also to guide research, prevention, and care strategies that truly reflect their needs. By amplifying patient perspectives, INTERCEPTOR ensures that those most impacted are heard, respected, and actively involved in shaping the future of oral cancer prevention in Europe.

 

Keep up with the latest news,
subscribe our Newsletter

linkedin

linkedin   x  

Project information

INTERCEPTOR aims to address the challenge of generating innovative and actionable pathways by engaging with the ‘critical practice’ dimensions of transformation.

A ‘critical practice’ approach explores transformation processes in practice across different dimensions which include research, policy, business, community and individual practices.

Action Contacts

Prof. Pierre Saintigny
Action Chair
+33(0)4 69 85 60 97
pierre.saintigny@lyon.unicancer.fr

Prof. Senada Koljenovic
Action Vice Chair
+31652090524
senada.koljenovic@uza.be

COST Contacts

Dr Rosella Magli
Science Officer
+3225333833
Rossella.Magli@cost.eu

Ms Carmencita Malimban
Administrative Officer
+3225333842
carmencita.malimban@cost.eu

COST    EN FUNDED

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu